Quotes are Powered By Forexpros, the Forex, Futures, and Stock
New Swedish breakthrough in
drug research especially those affecting inflammation disease
A new Swedish
research, which is being deemed as a new breakthrough area, can lead to
radically improved medical treatment of a number of inflammation
Lund University, Sweden, discovered that a protein has a central role
in the development of acute pancreatitis, inflammation of the pancreas.
As such, the researchers believe that there is now a clear target for
the development of new treatments and drugs as at this moment, such is
Maria Gomez, associate professor of physiology, at the University of
Lund, told radio Sweden that this has to do with breakthrough in
She told the
station that because studies on pancreatitis in different contexts have
been fully studies and there has been no new trails to follow. As such
according to her, in some ways their new research is a breakthrough.
about 9,000 Swedes suffer from pancreatitis, of them more than 1000 get
critically ill requiring intensive care. Deaths are not uncommon.
Pancreas is one of many serious acute inflammatory diseases. Scientists
in Lund have found that a well-known protein called NFAT, strongly
contributes to the development of pancreatitis.
"We were very
surprised that protein not previously been associated with acute
inflammation had great significance for acute pancreatitis," says
Henrik Thorlacius is professor of surgery.
open up new treatment options and drugs that block the particular
protein both acute pancreatitis and other acute inflammatory diseases.
The researchers are now continuing the mapping of the other diseases
that are affected by the particular protein.
confident that this is much more than just generalizability acute
pancreatitis, but also other acute inflammatory diseases such as sepsis
and bowel diseases, says Henrik Thorlacius.
The majority of
the country's intensive care beds are occupied by people who have some
form of acute inflammation and the right research on inflammation has
become increasingly important.
last 10 to 15 years, the focus of inflammation diseases has
increased in almost all the different diseases strands. Even among
those who were not considered to be based on inflammatory components.
If the protein
NFAT, which scientists believe, also affect the development of other
autoimmune diseases, a new drug development would be highly important.
"I believe that
such a substance would revolutionize the treatment of many acute
diseases," says Henrik Thorlacius.